Date published: 2026-5-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

Sur-8 Inhibitors

Sur-8 inhibitors are a class of chemical compounds designed to specifically target and inhibit the activity of Sur-8, a scaffold protein that plays a crucial role in Ras-MAPK (mitogen-activated protein kinase) signaling. Sur-8, also known as SHOC2, acts as a mediator in Ras signaling by interacting with Ras and other components of the MAPK pathway, facilitating the transmission of signals from membrane receptors to downstream effectors involved in cell growth, differentiation, and survival. By inhibiting Sur-8, these compounds interfere with the proper assembly and functioning of the Ras-MAPK signaling complex, thereby affecting signal transduction and altering cellular responses to extracellular stimuli.

The mechanism of Sur-8 inhibitors typically involves blocking the interaction between Sur-8 and Ras or other associated proteins within the MAPK pathway. Some inhibitors may disrupt the structural conformation of Sur-8, preventing it from serving as an effective scaffold for signaling components, while others may directly interfere with its binding sites. Researchers use Sur-8 inhibitors to explore the regulatory role of scaffold proteins in complex signaling networks, especially in pathways that control cell proliferation and differentiation. By inhibiting Sur-8, scientists can better understand the molecular mechanisms that govern Ras-MAPK signaling and how the spatial organization of signaling molecules contributes to the precision and specificity of cellular responses. These inhibitors are valuable tools for dissecting the intricate dynamics of protein-protein interactions in signal transduction pathways and for studying the broader implications of scaffold proteins like Sur-8 in cellular communication and regulation.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

A DNA methyltransferase inhibitor that might change the methylation status of the SHOC2 gene, potentially affecting its expression.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

This antibiotic binds to DNA and may inhibit RNA polymerase, which could reduce the transcription of SHOC2.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

An mTOR inhibitor that can result in decreased protein synthesis, possibly affecting the production of SHOC2.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$41.00
$84.00
$275.00
127
(6)

It inhibits translational elongation, which might lead to a general decrease in protein levels, including SHOC2.

Quercetin

117-39-5sc-206089
sc-206089A
sc-206089E
sc-206089C
sc-206089D
sc-206089B
100 mg
500 mg
100 g
250 g
1 kg
25 g
$11.00
$17.00
$110.00
$250.00
$936.00
$50.00
33
(2)

It can modulate signaling pathways and transcription factors that may influence SHOC2 gene expression.

Chloroquine

54-05-7sc-507304
250 mg
$69.00
2
(0)

By affecting endosomal/lysosomal pathways, chloroquine might indirectly influence SHOC2 expression.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$269.00
$1050.00
26
(2)

It inhibits RNA polymerase II and could lead to decreased transcription of genes such as SHOC2.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

By inhibiting JNK signaling, this compound could impact transcription factors related to SHOC2 expression.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

As a PI3K inhibitor, it might downregulate AKT/mTOR signaling, possibly impacting SHOC2 protein synthesis.